#Truvada

Armando Herrera sold adulterated and misbranded HIV drugs through companies in six states. He faces a maximum of five years in prison.

When given a choice, most women chose injectable cabotegravir over daily prevention pills.

Research on the links between tenofovir and other antiretrovirals, SARS-CoV-2 infection and COVID severity has produced mixed results.

There are now three FDA-approved PrEP medications in the United States—two are pills, and one is a shot.

The $3.6 billion antitrust court case cleared Gilead Sciences and Teva of delaying the release of generic Truvada and other HIV meds.

A jury in May ruled in favor of Gilead Sciences, maker of HIV prevention pills. Now the government wants a judge to overturn the verdict.

TDF/FTC is effective for cisgender women who take at least four pills per week, but many struggle to reach this level of adherence.

The battle between the CDC and Gilead over the patent for Truvada and Descovy for HIV prevention is heading to court.

Several mechanisms may play a role, including persistent virus and ongoing immune dysregulation.

Changes in kidney function were small for those using TDF/FTC either daily or on-demand for HIV prevention.

Switching from TAF to TDF may help people lose weight, but this must be balanced against the risk of kidney problems and bone loss.

Although 71% of survey respondents were aware of PrEP, just 19% had ever used HIV prevention pills.

Children born to mothers on PrEP appeared to have normal growth and cognitive development.

Apretude for HIV prevention is as effective for trans women as it is for gay men, with no adverse effects on hormone therapy.

The prevention pills—and newer methods—have averted countless HIV cases, but they still aren’t reaching everyone who could benefit.

Requiring insurers to cover PrEP encourages homosexual behavior, promiscuity and drug use, claims a federal lawsuit by Jonathan Mitchell.